Cholelithiasis, cholecystectomy, and liver disease

Area of Science:

• Hepatology
• Gastroenterology
• Epidemiology

Background:

• Gallstones (cholelithiasis) and fatty liver disease share risk factors like obesity and insulin resistance.
• Previous research suggests a link between gallbladder issues and liver health.

Purpose of the Study:

• To investigate if cholelithiasis or a history of cholecystectomy increases the likelihood of elevated liver enzymes or cirrhosis development.
• To analyze the association between gallbladder disease and liver enzyme levels or cirrhosis incidence.

Main Methods:

• Utilized cohort data from the first National Health and Nutrition Examination Survey (NHANES) for long-term follow-up.
• Employed cross-sectional data from the third NHANES (1988-1994) with ultrasonography for gallbladder assessment.
• Compared incidence of cirrhosis-related hospitalization/death and serum alanine aminotransferase (ALT) or gamma-glutamyl transferase (GGT) levels between groups.

Main Results:

• Previous cholecystectomy was associated with a twofold increased risk of cirrhosis hospitalization or death (aHR 2.1, 95% CI 1.1-4.0).
• Patients with prior cholecystectomy showed higher odds of elevated ALT (aOR 1.8, 95% CI 1.3-2.5) and GGT (aOR 1.7, 95% CI 1.1-2.6).
• No independent association was found between cholelithiasis and elevated serum ALT or GGT levels.

Conclusions:

• Cholecystectomy serves as a predictor for cirrhosis development and is linked to elevated liver enzymes.
• Cholelithiasis, independently, is not associated with serum liver enzyme levels.
• The association between cholelithiasis and cirrhosis development requires further investigation.